BlackRock Health Sciences Trust (BME) — Capital Reinvestment Ratio
BlackRock Health Sciences Trust (BME) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow ($959.34K) in capital expenditures ($5.00). See BME equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BlackRock Health Sciences Trust Capital Reinvestment Ratio (2023–2023)
This chart tracks BlackRock Health Sciences Trust's Capital Reinvestment Ratio across 1 annual periods. Check BlackRock Health Sciences Trust (BME) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for BlackRock Health Sciences Trust (2023–2023)
Year-by-year Capital Reinvestment Ratio for BlackRock Health Sciences Trust from 2023 to 2023. For live market cap and broader valuation context, see BME market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 0.00x | $32.02 Million | $3.00 | — |